TP53 and hepatocellular carcinoma: Silencing Rictor alone had a relatively modest or negligible impact on cell growth of TP53-mutated hepatoma cell lines, including PLC/PRF/5 (with a TP53 p.R249S mutation) and Huh7 (with a TP53 p.Y220C mutation) (Fig. 1C, D).